Sexual Dysfunction

April 09, 2020

New research indicates having at least one symptom of vulvovaginal atrophy is linked to significant impaired sexual function for postmenopausal women.

November 22, 2019

According to research published in Menopause, vaginal atrophy-a treatable condition-appears to be the most impactful factor for perimenopausal women and declining sexual function.

September 09, 2019

A recent study examined how bicycle seats may play a role in the prevalence of sexual dysfunction among female adult bicyclists.

July 17, 2019

Ob/gyns treating patients with epilepsy should be aware of their higher risk for sexual dysfunction while also recognizing that the cause may be multifactorial. 

July 02, 2019

Bremelanotide is an injectable indicated for premenopausal women with hypoactive sexual desire disorder (HSDD).

October 16, 2018

A recent study examined similarities and differences between women who were exposed to sexual abuse and those with dyspareunia and is the first to actively compare these groups.

September 11, 2018

A new study highlighted how common sexual dysfunction is among middle-aged persons and if the prevalence among Canadians is consistent with American and British reports. 

August 09, 2018

Dilator therapy can be extremely successful in treating superficial dyspareunia, but compliance is often poor. A new type of vaginal dilator that gives women more control aims to address the issue.

August 09, 2018

A recent study quantified how much the treatment effect of pharmacologic modalities for female sexual dysfunction could be attributed to the placebo effect.

July 11, 2018

An oral selective estrogen receptor modulator approved for treatment of mild to moderate dyspareunia in menopausal women reduced signs and symptoms of atrophy in the vulva, vestibule, urethral meatus and vagina region, according to results of a prospective open-label pilot study